首页>外文期刊>Global & Regional Health Technology Assessment

Global & Regional Health Technology Assessment

中文名称：全球和区域卫生技术评估

ISSN：
出版周期：-

发文量：157

期刊论文

热门论文

年度选择

2018
- 第1期
2017
- 第1期
2016
- 第1期
- 第2期
- 第3期
2015
- 第1期
- 第2期
- 第3期
2014
- 第1期
- 第2期

更多>>

全选（0）

1.Including Health Economic Analysis in Pilot Studies: Lessons Learned from a Cost-Utility Analysis within the PROSPECTIV Pilot Study:

机译：在试点研究中包括健康经济分析：在PROSPECTIV试点研究中从成本－效用分析中学到的经验教训：
- 作者：Richéal M. Burns;Jane Wolstenholme;Bethany Shinkins;Emma Frith;Lauren Matheson;Peter W. Rose;Eila Watson
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
2.Analisi di Budget Impact di Ticagrelor nel Trattamento di Prevenzione in Pazienti con Sindrome Coronarica Acuta:

机译：替卡格雷用于预防急性冠脉综合征的预算影响分析：
- 作者：Gian Piero Perna;Roberto Ravasio;Antonio Ricciardelli
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
3.Cost-Effectiveness of Azacitidine Compared with Low-Doses of Chemotherapy (LDC) in Myelodysplastic Syndrome (MDS):

机译：阿扎胞苷与低剂量化疗（LDC）在骨髓增生异常综合症（MDS）中的成本效果：
- 作者：Myrna Candelaria Hernández;Xavier López Karpovitch;Francisco Javier Mijangos;Efreen Monta?o;Arely Lemus Carmona;Silvia Guzmán Vázquez;Herman Soto Molina
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
4.Impatto Economico Dei Biosimilari in Italia: Passato, Presente e Futuro di Infliximab ed Etanercept:

机译：意大利生物仿制药的经济影响：英夫利昔单抗和依那西普的过去，现在和未来：
- 作者：Andrea Marcellusi;Luca Bianchi;Antonio Gasbarrini;Guido Valesini;Francesco Saverio Mennini
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
5.La Gestione Ambulatoriale Della Terapia Anticoagulante Orale (TAO) Nelle Cure Primarie: L'esperienza Dell'Associazione “Medicina di Gruppo di Masate”:

机译：初级保健中的口服抗凝治疗（OAT）的门诊管理：“ Masate团体医学”协会的经验：
- 作者：Fiorenzo Massimo Corti;Contardo Luigi Corbetta;Maria P. Consuelo Lampreda;Giovanni Gancitano;Matteo Dionisi
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
6.Analysis of Productivity Costs in Cancer: A Systematic Review:

机译：癌症生产成本分析：系统评价：
- 作者：Jordi Gol-Montserrat;María Luisa M. del Burgo;Luis Quecedo;Juan E. del Llano
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
- CancerFriction costHuman capitalIndirect costsProductivity costsSystematic review;
7.Rapid Reviews with Health-Technology Assessments in Reimbursement Systems – an Examination of Ireland as a Case Study:

机译：在报销系统中对卫生技术评估进行快速审查–以案例研究爱尔兰为例：
- 作者：Aileen Murphy;Sandra Redmond
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
- Health technology assessmentIrelRapid reviewsReimbursement;
8.Current Management of Severe Refractory Asthma in Italy: Analysis of Real-World Data:

机译：意大利重度难治性哮喘的当前管理：真实数据分析：
- 作者：Antonella Pedrini;Elisa Rossi;Silvia Calabria;Letizia Dondi;Nello Martini
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
- Burden of illnessCostsDatabase analysisPrevalenceReal worldSevere asthma;
9.When Simple Becomes Complicated: Why Excel Should Lose its Place at the Top Table:

机译：当简单变得复杂时：为什么Excel应该在最上面的表格上失去位置：
- 作者：Gianluca Baio;Anna Heath
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
10.Valore delle tecnologie sanitarie, HTA, decisioni:

机译：卫生技术，HTA和决策的价值：
- 作者：Carlo Lucioni;Claudio Jommi
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
11.Cost Advantage of Fluocinolone Acetonide Implant (ILUVIEN?) versus Ranibizumab in the Treatment of Chronic Diabetic Macular Oedema:

机译：氟轻松氟替尼酮（ILUVIEN？）与雷珠单抗相比在慢性糖尿病性黄斑水肿治疗中具有成本优势：
- 作者：Fahd Quhill;Annette Beiderbeck
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
12.Una Valutazione Economica Delle Sequenze Terapeutiche nel Trattamento di Prima Linea Della Leucemia Linfatica Cronica in Pazienti Unfit non Pretrattati:

机译：对未经预处理的不适合患者的慢性淋巴白血病的一线治疗的治疗顺序的经济评估：
- 作者：Antonio Cuneo;Roberto Ravasio;Nicola Amedeo Mazzanti
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
- Chronic lymphocytic leukemiaCostEconomicTherapeutic sequencesObinutuzumabTime to next treatment;
13.Valutazione Economica Dell'impatto Organizzativo di Differenti Tecniche di Ibridazione in Situ per la Determinazione Dello Stato di HER2 nel Carcinoma Alla Mammella:

机译：对确定乳腺癌中HER2状况的不同原位杂交技术的组织影响进行的经济评估：
- 作者：Roberto Ravasio;Davide Paolini;Matteo Dionisi;Vincenzo Arena
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
- CostFISHHER2HybridizationPathology;
14.Qual è il Giusto Place in Therapy Dell'olmesartan?:

机译：奥美沙坦疗法在哪里正确？
- 作者：Antonio Addis;Dr. Francesco Trotta
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
- Angiotensin receptor blockersDrug expenditureDrug utilizationOlmesartanPlace in therapyPost-marketing safety;
15.Including Health Economic Analysis in Pilot Studies: Lessons Learned from a Cost-Utility Analysis within the PROSPECTIV Pilot Study:

机译：在试点研究中包括健康经济分析：在PROSPECTIV试点研究中从成本－效用分析中学到的经验教训：
- 作者：Richéal M. Burns;Jane Wolstenholme;Bethany Shinkins;Emma Frith;Lauren Matheson;Peter W. Rose;Eila Watson
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
- CostsEconomic evaluationPilot studyProstate cancerQuality of life;
16.Valutazione Della Politica di Pricing Dei Farmaci Oncologici Innovativi: Correlazione Tra Costi e Sopravvivenza in 15 Paesi Europei:

机译：创新的癌症药物定价政策评估：15个欧洲国家的成本与生存率的相关性
- 作者：Daniele Mengato;Francesca Decannas
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
- Anticancer drugCorrelationOncologyOverall survivalPricing policyProgression free survival;
17.Mortality Cost of Duchenne Muscular Dystrophy:

机译：杜兴肌营养不良症的死亡率：
- 作者：Erik Landfeldt;Michelle Eagle;Volker Straub;Hanns Lochmüller;Katharine Bushby;Peter Lindgren
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
- Cost of illnessHealth policyNeuromuscular diseases;
18.Corticosteroidi per via Intravitreale per il Trattamento Dell'edema Maculare: Revisione e Valutazione Della Qualità Dell'evidenza:

机译：玻璃体内糖皮质激素治疗黄斑水肿：证据质量的审查和评估：
- 作者：Marco Marchetti;Luz Irene Urbina;Marco Oradei;Matteo Ruggeri;Pierluigi Navarra
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
- DexamethasoneEvidence-based medicineFluocinolone acetonideIntravitreal injectionsMacular edemaTriamcinolone acetonide;
19.Cost Advantage of Fluocinolone Acetonide Implant (ILUVIEN?) versus Ranibizumab in the Treatment of Chronic Diabetic Macular Oedema:

机译：氟轻松氟替尼酮（ILUVIEN？）与雷珠单抗相比在慢性糖尿病性黄斑水肿治疗中具有成本优势：
- 作者：Fahd Quhill;Annette Beiderbeck
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
- Cost savingDiabetic retinopathyFluocinolone acetonideIntravitreal injectionsMacular oedemaRanibizumab;
20.Mortality Cost of Duchenne Muscular Dystrophy:

机译：杜兴肌营养不良症的死亡率：
- 作者：Erik Landfeldt;Michelle Eagle;Volker Straub;Hanns Lochmüller;Katharine Bushby;Peter Lindgren
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
21.Valore delle tecnologie sanitarie, HTA, decisioni:

机译：卫生技术，HTA和决策的价值：
- 作者：Carlo Lucioni;Claudio Jommi
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
- InnovationHTANational health system;
22.Más allá Del análisis Coste-Efectividad. Precios Basados en el Valor y Financiación Orientada a Resultados Como Vía de Sostenibilidad Para el SNS en Espa?a:

机译：超越成本效益分析。基于价值的定价和以结果为导向的融资是西班牙NHS可持续发展的途径：
- 作者：Alvaro Hidalgo-Vega
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
23.Corticosteroidi per via Intravitreale per il Trattamento Dell'edema Maculare: Revisione e Valutazione Della Qualità Dell'evidenza:

机译：玻璃体内糖皮质激素治疗黄斑水肿：证据质量的审查和评估：
- 作者：Marco Marchetti;Luz Irene Urbina;Marco Oradei;Matteo Ruggeri;Pierluigi Navarra
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
24.Il Costo Ospedaliero di Trattamento di un Episodio di Infezione da Clostridium Difficile in Italia:

机译：在意大利治疗艰难梭菌感染的医院费用：
- 作者：Nicola Petrosillo;Roberto Ravasio
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2017年第1期
25.Economic burden of disease of uncontrolled acromegalic patients: the acromegaly Italian collaborative study group:

机译：无法控制的肢端肥大症患者的疾病经济负担：肢端肥大症的意大利合作研究小组：
- 作者：Francesco S. Mennini;Raffaella Viti;Chiara Bini;Andrea Marcellusi;Fabio Palazzo
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
26.The economic impact of the correct insulin injection technique associated with the use of 4 mm 32G needles in the treatment of patients with type 2 diabetes:

机译：正确的胰岛素注射技术与4 mm 32G针头在2型糖尿病患者中的治疗相关的经济影响：
- 作者：Roberto Ravasio;Giorgio Grassi
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- 4 mm 32G needlestype 2 diabetesinsulin injection techniquecosteducational programmeItalian National Health Service;
27.A budget impact analysis of a clinical medication review of patients in an Irish university teaching hospital:

机译：在爱尔兰大学教学医院对患者进行临床用药审查的预算影响分析：
- 作者：Alan Kearney;Elaine K Walsh;Ann Kirby;Ciaran Halleran;Derina Byrne;Jennifer Haugh;Laura J Sahm
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- Budget impact analysiscost analysismedication reviewpharmacy;
28.A comparative examination of healthcare use related to hearing impairment in Europe:

机译：欧洲与听力障碍相关的医疗保健用途的比较检查：
- 作者：Mimi Xiao;Ciaran O’Neill
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- Hearing impairmentService usePrimary careSecondary care;
29.Economic burden of disease of uncontrolled acromegalic patients: the acromegaly Italian collaborative study group:

机译：无法控制的肢端肥大症患者的疾病经济负担：肢端肥大症的意大利合作研究小组：
- 作者：Francesco S. Mennini;Raffaella Viti;Chiara Bini;Andrea Marcellusi;Fabio Palazzo
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- cost of illnessindirect costpatient cost;
30.The hospitalization burden of influenza: just the tip of the iceberg?:

机译：流感的住院负担：只是冰山一角？：
- 作者：Arianna Bertolani;Giovanni Fattore;Fabrizio Pregliasco
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- ComplicationsHospitalization costsInfluenzaItalyNegative binomial regression;
31.Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives:

机译：从医院和付款方的角度分析意大利利妥昔单抗生物仿制药的预算影响分析：
- 作者：Carla Rognoni;Arianna Bertolani;Claudio Jommi
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- Rituximabbiosimilarbudget impact analysiseconomic evaluation;
32.Evaluación del impacto presupuestario del servicio integral de asistencia domiciliaria nutricional:

机译：评估综合营养家庭护理服务的预算影响：
- 作者：Javier Nu?ez Alfonsel;Benedetto Ielpo;Villareal Garcóa-Lomas M;Cristóbal Belda Iniesta
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- Cirugía digestivacostesestancia hospitalariaevaluación económicaimpacto presupuestarionutrición domiciliarianutrición parenteral;
33.Corrigendum:

机译：更正
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
34.Patients’ Associations and HTA for medicines: actual and future role in Italy:

机译：患者协会和药品HTA：在意大利的实际和未来角色：
- 作者：Claudio Jommi;Arianna Bertolani
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- HTAPatients’ AssociationsMedicinesItaly;
35.I costi dei pazienti con patologie infiammatorie dell’intestino (Malattia di Crohn e colite ulcerosa). Studio real world in Italia:

机译：炎症性肠病（克罗恩病和溃疡性结肠炎）患者的费用。意大利的真实世界工作室：
- 作者：Stefano Capri;Antonio Russo
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- Biologicscost of illnessCrohn’s diseaseinflammatory bowel diseaseItalyreal-world studyulcerative colitis;
36.Il trattamento con farmaci intravitreali anti-VEGF in pazienti na?ve in Italia:

机译：在意大利的无症状患者中使用玻璃体内抗VEGF药物治疗：
- 作者：M Albrecht;M Nica;D Colombo;C Ferri;P Tadini;U Introini;F Bandello
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- AfliberceptIntravitreal anti-VEGF treatmentRanibizumabVascular-endothelial-growth-factor;
37.Patients’ Associations and HTA for medicines: actual and future role in Italy:

机译：患者协会和药品HTA：在意大利的实际和未来角色：
- 作者：Claudio Jommi;Arianna Bertolani
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
38.The hospitalization burden of influenza: just the tip of the iceberg?:

机译：流感的住院负担：只是冰山一角？：
- 作者：Arianna Bertolani;Giovanni Fattore;Fabrizio Pregliasco
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
39.The economic impact of the correct insulin injection technique associated with the use of 4 mm 32G needles in the treatment of patients with type 2 diabetes:

机译：正确的胰岛素注射技术与4 mm 32G针头在2型糖尿病患者中的治疗相关的经济影响：
- 作者：Roberto Ravasio;Giorgio Grassi
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
40.Analisi di budget impact del biosimilare di etanercept: lo scenario italiano:

机译：依那西普生物仿制药的预算影响分析：意大利方案：
- 作者：Roberto Ravasio;Giampiero Girolomoni;Roberto Gorla
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- Drug Budget ImpactEtanerceptBiosimilarItalian National Health Service;
41.Burden of disease, healthcare pathways and costs of cardiovascular high-risk patients with type 2 diabetes: a real world analysis:

机译：心血管疾病高风险2型糖尿病患者的疾病负担，医疗保健途径和费用：真实世界分析：
- 作者：Carlo Piccinni;Letizia Dondi;Giulia Ronconi;Antonella Pedrini;Nello Martini;Giulio Marchesini
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- DiabetesCardiovascular high-riskHealthcare pathwaysHealth costsBurden of diseaseReal-world evidence;
42.Costo-Efficacia di cabozantinib nel trattamento di seconda linea del tumore a cellule renali metastatico (mRCC) in Italia:

机译：卡波替尼在意大利转移性肾细胞癌（mRCC）的二线治疗中的成本效益：
- 作者：Sanja Stanisic;Americo Cicchetti;Camillo Porta;Giuseppe Procopio;Patrizia Berto
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- Cost-effectivenessItalymetastatic renal cell carcinomasecond line;
43.Alirocumab in the management of primary hypercholesterolaemia or mixed dyslipidaemia: A budget impact analysis – Italian perspective:

机译：Alirocumab在原发性高胆固醇血症或混合性血脂异常的管理中：预算影响分析–意大利的观点：
- 作者：Alessia Marocco;Sanja Stanisic;Francesca Fanelli;Francesco Damele;Furio Colivicchi
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- Alirocumabcostcost analysisdyslipidaemiasItalymonoclonal antibody;
44.A budget impact analysis of a clinical medication review of patients in an Irish university teaching hospital:

机译：在爱尔兰大学教学医院对患者进行临床用药审查的预算影响分析：
- 作者：Alan Kearney;Elaine K Walsh;Ann Kirby;Ciaran Halleran;Derina Byrne;Jennifer Haugh;Laura J Sahm
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
45.Alirocumab in the management of primary hypercholesterolaemia or mixed dyslipidaemia: A budget impact analysis – Italian perspective:

机译：Alirocumab在原发性高胆固醇血症或混合性血脂异常的管理中：预算影响分析–意大利的观点：
- 作者：Alessia Marocco;Sanja Stanisic;Francesca Fanelli;Francesco Damele;Furio Colivicchi
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
46.Cost-description and multiple imputation of missing values: the SATisfaction and adherence to COPD treatment (SAT) study:

机译：成本描述和缺失值的多重估算：SAT的满意度和对COPD治疗的依从性（SAT）研究：
- 作者：Carlo Lazzaro;Fabiano Di Marco;Nicola Scichilone;Fulvio Braido;Marco Contoli;Paola Rogliani;Pierachille Santus;Valentina Acciai;Carla Scognamillo;Irene Olivi;Angelo Guido Corsico
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- COPDItalySAT studycost descriptionmultiple imputation;
47.Epidemiology and economic impact of moderate and severe neurotrophic keratopathy in Italy:

机译：意大利中度和重度神经营养性角膜病的流行病学和经济影响：
- 作者：Sanja Stanisic;Alessia Marocco;Anna Gallo;Paolo Rama;Marta Sacchetti;Maurizio Rolando;Augusto Pocobelli;Roberto Ceccuzzi;Andrea Leonardi;Rita Mencucci;Emilio Pedrotti;Elisa Postorino;Maurizio Mascia;Lucia R Mazzamuto;Luisanna Prisco;Floortje Van Nooten;Patrizia Berto
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- Neurotrophic keratopathycorneal diseasescorneal sensitivitycornea/innervationkeratitis/therapycost analysis;
48.Tempi di accesso ai farmaci in Italia nel periodo 2015-2017: Analisi delle tempistiche di valutazione dell’Agenzia Italiana del Farmaco:

机译：2015-2017年意大利的药品获取时间：意大利药品管理局的评估时间分析：
- 作者：Dario Lidonnici;Virginia Ronco;Martina Isernia;Elena Lanati;Claudio Jommi;Pier Luigi Canonico;Armando A. Genazzani
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- PriceReimbursementInnovative drugsTime-to-market;
49.Analisi di impatto sul budget di differenti analoghi ad azione rapida dell’insulina in Italia:

机译：意大利不同速效胰岛素类似物的预算影响分析：
- 作者：Elena P. Lanati;Paola La Malfa;Arianna Iorio;Francesco S. Mennini;Francesca Fanelli;Sandro Gentile
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- diabetesinsulin glulisinenational expenditure;
50.Budget impact model of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary disease in Italy based on the FLAME study:

机译：根据FLAME研究，茚达特罗/格隆铵在意大利治疗慢性阻塞性肺疾病的预算影响模型：
- 作者：Andrea Aiello;Daniela Ritrovato;Claudia Pitotti
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- Budget impact analysischronic obstructive pulmonary diseaseindacaterol/glycopyrroniumItaly;
51.Analisi di Budget Impact su modelli di acquisto e gestione degli ausili per l’incontinenza urinaria a confronto:

机译：比较了尿失禁辅助用品购买和管理模式的预算影响分析：
- 作者：FS Mennini;P Pisanti;S Terzoni;EP Lanati;A Marcellusi;A Marcelli;A Iorio
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- Budget ImpactUrinary Incontinence;
52.Accesso precoce al mercato: dalle approvazioni condizionate di EMA agli accordi negoziali particolari di AIFA:

机译：抢先进入市场：从EMA的有条件批准到AIFA的特殊谈判协议：
- 作者：Federico Villa;Claudio Jommi;Armando Genazzani;Sara Antignani;Simona Montilla;Mario Melazzini
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- AIFAConditional Marketing AuthorisationEMAManaged Entry AgreementsMarket AccessRegulatory AffairsUnder Exceptional Circumstances;
53.Assessing social and economic impact of subcutaneous mAbs in oncology:

机译：评估皮下单克隆抗体在肿瘤学中的社会和经济影响：
- 作者：Americo Cicchetti;Silvia Coretti;Daniele Mascia;Nicola Mazzanti;Pietro Refolo;Francesca R. Rolli;Filippo Rumi
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- AntibodiesMonoclonalHealth Technology AssessmentRegression analysisEconomicSocial impactPatient Satisfaction;
54.Mean cost per number needed to treat of baricitinib versus adalimumab in the treatment of rheumatoid arthritis in Italy:

机译：在意大利治疗类风湿关节炎所需的巴立替尼和阿达木单抗治疗所需的平均费用：
- 作者：Roberto Ravasio;Silvia Antonelli;Veronica Rogai;Walid Fakhouri;Jean Philippe Capron;Serena Losi
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
- Adalimumabnumber needed to treatpharmacoeconomicsrheumatoid arthritisrheumatologybaricitinib;
55.Epidemiology and economic impact of moderate and severe neurotrophic keratopathy in Italy:

机译：意大利中度和重度神经营养性角膜病的流行病学和经济影响：
- 作者：Sanja Stanisic;Alessia Marocco;Anna Gallo;Paolo Rama;Marta Sacchetti;Maurizio Rolando;Augusto Pocobelli;Roberto Ceccuzzi;Andrea Leonardi;Rita Mencucci;Emilio Pedrotti;Elisa Postorino;Maurizio Mascia;Lucia R Mazzamuto;Luisanna Prisco;Floortje Van Nooten;Patrizia Berto
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
56.I costi dei pazienti con patologie infiammatorie dell’intestino (Malattia di Crohn e colite ulcerosa). Studio real world in Italia:

机译：炎症性肠病（克罗恩病和溃疡性结肠炎）患者的费用。意大利的真实世界工作室：
- 作者：Stefano Capri;Antonio Russo
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期
57.Il trattamento con farmaci intravitreali anti-VEGF in pazienti na?ve in Italia:

机译：在意大利的无症状患者中使用玻璃体内抗VEGF药物治疗：
- 作者：M Albrecht;M Nica;D Colombo;C Ferri;P Tadini;U Introini;F Bandello
- 期刊名称：《Global & Regional Health Technology Assessment》 | 2018年第1期

客服邮箱：kefu@zhangqiaokeyan.com

客服微信
服务号